cimoxatone has been researched along with 3-methoxy-4-hydroxyphenylglycol sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deniker, P; Lesage, A; Lôo, H; Olié, JP; Poirier, MF; Rovei, V; Strolin Benedetti, M | 1 |
| Dordain, G; Dostert, P; Eschalier, A; Lesage, A; Rovei, V; Strolin Benedetti, M; Zarifian, E | 1 |
2 trial(s) available for cimoxatone and 3-methoxy-4-hydroxyphenylglycol sulfate
| Article | Year |
|---|---|
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1983 |
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.
Topics: Adult; Circadian Rhythm; Humans; Hydrocortisone; Kinetics; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Prolactin | 1984 |